MTOR and cancer: These pathways include signaling cascades triggered by ephrin receptors, integrin-linked kinase (ILK), hypoxic conditions, bone morphogenetic proteins (BMPs), hepatic fibrosis, mammalian target of rapamycin (mTOR) activation, and adherens junction remodeling, which are essential for cancer-related EMT [73].